We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.1B
AUM Growth
+$5.57B
(+17%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$2.28B |
| 2 |
Otis Worldwide
OTIS
|
+$193M |
| 3 |
Burlington
BURL
|
+$191M |
| 4 |
AbbVie
ABBV
|
+$178M |
| 5 |
Wayfair
W
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Lockheed Martin
LMT
|
+$339M |
| 3 |
Johnson & Johnson
JNJ
|
+$262M |
| 4 |
Pfizer
PFE
|
+$167M |
| 5 |
Target
TGT
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 11.33% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
SBA Communications
SBAC
$19.1B
| $90.5M | 0.23% |
303,700
+139,900
| +85% | +$41.3M |
|
102
Intuit
INTU
$87.9B
| $89.7M | 0.23% |
302,700
+107,500
| +55% | +$29.5M |
|
103
Cameco
CCJ
$39B
| $89.5M | 0.23% |
8,736,089
-2,454,633
| -22% | -$24.5M |
|
104
ServiceNow
NOW
$119B
| $88.9M | 0.23% |
1,097,000
-126,500
| -10% | -$8.93M |
|
105
Baxter International
BAX
$14.6B
| $88.6M | 0.23% |
1,029,352
-172,676
| -14% | -$15M |
|
106
Willis Towers Watson
WTW
$31.7B
| $88.5M | 0.23% |
449,488
+124,850
| +38% | +$23.9M |
|
107
Charter Communications
CHTR
$17.2B
| $88.2M | 0.23% |
173,015
-109,996
| -39% | -$55.8M |
|
108
Public Service Enterprise Group
PEG
$38.1B
| $86.8M | 0.22% |
1,766,184
+890,000
| +102% | +$44.4M |
|
109
Sempra
SRE
$57.5B
| $85.1M | 0.22% |
1,452,600
-563,200
| -28% | -$34.6M |
|
110
Altria Group
MO
$114B
| $84.2M | 0.22% |
2,144,132
+14,100
| +0.7% | +$550K |
|
111
Sensata Technologies
ST
$6.83B
| $83.5M | 0.21% |
+2,243,388
| New | +$79.3M |
|
112
Becton Dickinson
BDX
$46.8B
| $81.7M | 0.21% |
349,940
+264,493
| +310% | +$63.7M |
|
113
Citizens Financial Group
CFG
$30.7B
| $80.7M | 0.21% |
3,198,239
-1,617,035
| -34% | -$36.7M |
|
114
Fortune Brands Innovations
FBIN
$6.22B
| $80.5M | 0.21% |
1,473,430
+995,455
| +208% | +$46.3M |
|
115
Analog Devices
ADI
$177B
| $80.5M | 0.21% |
656,357
-629,000
| -49% | -$69.1M |
|
116
Prologis
PLD
$135B
| $79.9M | 0.2% |
856,029
+14,300
| +2% | +$1.28M |
|
117
Cigna
CI
$74.7B
| $79.8M | 0.2% |
424,998
-800
| -0.2% | -$152K |
|
118
Capital One
COF
$134B
| $78.2M | 0.2% |
1,249,129
-1,119,248
| -47% | -$69.7M |
|
119
NXP Semiconductors
NXPI
$56.7B
| $77.8M | 0.2% |
682,065
+177,965
| +35% | +$17.8M |
|
120
Evergy
EVRG
$19.1B
| $77.6M | 0.2% |
1,308,100
+345,500
| +36% | +$20.5M |
|
|
121
Johnson & Johnson
JNJ
$613B
| $77M | 0.2% |
547,810
-1,798,500
| -77% | -$262M |
|
122
Elevance Health
ELV
$82.7B
| $76.8M | 0.2% |
291,893
+2,700
| +0.9% | +$720K |
|
123
Mondelez International
MDLZ
$78.7B
| $76.1M | 0.19% |
1,488,397
-153,200
| -9% | -$7.87M |
|
124
Costco
COST
$422B
| $75.8M | 0.19% |
250,110
-247,010
| -50% | -$75.2M |
|
125
Micron Technology
MU
$930B
| $75.3M | 0.19% |
1,462,530
-28,400
| -2% | -$1.34M |
|
Similar funds
Adage Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.
- Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
- Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
- Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
- Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
- Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
- Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
- Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.
Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.